Israel Englander’s West Pharmaceutical WST Stock Holding History

Israel Englander’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$574K	Buy	+1,600	New	+$489K	﹤0.01%	4685
2025 Q3	–	Sell	-4,300	Closed	-$941K	–	6522
2025 Q2	$941K	Sell	4,300 -27,100	-86%	-$5.79M	﹤0.01%	4453
2025 Q1	$7.03M	Buy	+31,400	New	+$8.65M	﹤0.01%	2527
2024 Q4	–	Sell	-4,500	Closed	-$1.35M	–	6524
2024 Q3	$1.35M	Sell	4,500 -9,300	-67%	-$2.85M	﹤0.01%	4030
2024 Q2	$4.55M	Buy	+13,800	New	+$4.88M	﹤0.01%	2811
2023 Q4	–	Sell	-10,000	Closed	-$3.75M	–	6611
2023 Q3	$3.75M	Buy	10,000 +5,000	+100%	+$1.93M	﹤0.01%	2986
2023 Q2	$1.91M	Buy	5,000 +2,000	+67%	+$714K	﹤0.01%	3516
2023 Q1	$1.04M	Buy	+3,000	New	+$877K	﹤0.01%	4061
2018 Q4	–	Sell	-100,000	Closed	-$12.3M	–	4234
2018 Q3	$12.3M	Buy	+100,000	New	+$11.2M	0.02%	1159

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Israel Englander's WST Position: Q2 2026 in Review

Israel Englander increased its West Pharmaceutical (WST) stake by 55% in Q2 2026, buying an estimated $2.3M and bringing the position to 21,290 shares worth $7.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

Israel Englander first reported a position in WST in Q4 2013 and has held it in 46 quarters since. The position peaked at $204M in Q1 2024. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Israel Englander held 21,290 shares of West Pharmaceutical worth $7.64M as of Q2 2026.
Israel Englander bought 7,515 West Pharmaceutical shares in Q2 2026, an estimated $2.3M.
West Pharmaceutical made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2577 holding.
Israel Englander first reported a position in West Pharmaceutical in Q4 2013 and has held it in 46 quarters since.
Israel Englander's West Pharmaceutical position peaked at $204M in Q1 2024.
827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.